Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer, Hocine R. Hocine, Géraldine Gentric, et al.
Cancer Discovery (2020) Vol. 10, Iss. 9, pp. 1330-1351
Open Access | Times Cited: 599

Showing 1-25 of 599 citing articles:

Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1058
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 739
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Niño, Hanrui Wu, Kaitlyn D. LaCourse, et al.
Nature (2022) Vol. 611, Iss. 7937, pp. 810-817
Open Access | Times Cited: 445
Fibroblasts as immune regulators in infection, inflammation and cancer
Sarah Davidson, Mark Coles, Tom Thomas, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 704-717
Open Access | Times Cited: 374
Cancer-associated fibroblasts in the single-cell era
Dor Lavie, Aviad Ben‐Shmuel, Neta Erez, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 793-807
Open Access | Times Cited: 328
Deciphering breast cancer: from biology to the clinic
Emma Nolan, Geoffrey J. Lindeman, Jane E. Visvader
Cell (2023) Vol. 186, Iss. 8, pp. 1708-1728
Open Access | Times Cited: 326
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
Huocong Huang, Zhaoning Wang, Yuqing Zhang, et al.
Cancer Cell (2022) Vol. 40, Iss. 6, pp. 656-673.e7
Open Access | Times Cited: 319
Spatially confined sub-tumor microenvironments in pancreatic cancer
Barbara T. Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Cell (2021) Vol. 184, Iss. 22, pp. 5577-5592.e18
Open Access | Times Cited: 278
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts
Sonakshi Bhattacharjee, Florian Hamberger, Aashreya Ravichandra, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 11
Open Access | Times Cited: 246
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Chang Yang, Bairong Xia, Zhao-Cong Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 240
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance
Phillip M. Galbo, Xingxing Zang, Deyou Zheng
Clinical Cancer Research (2021) Vol. 27, Iss. 9, pp. 2636-2647
Open Access | Times Cited: 237
Cancer-associated fibroblasts: overview, progress, challenges, and directions
Qinrong Ping, Ruping Yan, Xin Cheng, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 9, pp. 984-999
Open Access | Times Cited: 228
Biomarkers for cancer-associated fibroblasts
Chencheng Han, Tongyan Liu, Rong Yin
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 219
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 214
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
Satyen H. Gohil, J. Bryan Iorgulescu, David A. Braun, et al.
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 4, pp. 244-256
Open Access | Times Cited: 210
Cancer associated-fibroblast-derived exosomes in cancer progression
Chao Li, Adilson Fonseca Teixeira, Hong‐Jian Zhu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 208
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer
Adele M. Nicolas, Marina Pešić, Esther Engel, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 168-184.e13
Open Access | Times Cited: 207
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 202
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
Akshay T. Krishnamurty, Justin A. Shyer, Minh Thai, et al.
Nature (2022) Vol. 611, Iss. 7934, pp. 148-154
Open Access | Times Cited: 197
Applications of single-cell RNA sequencing in drug discovery and development
Bram Van de Sande, Joon Sang Lee, Euphemia Mutasa-Gottgens, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 496-520
Open Access | Times Cited: 196
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 190
Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes
James A. Diao, Jason K. Wang, Wan Fung Chui, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 182
Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer
Kathleen M. McAndrews, Yang Chen, J. Kebbeh Darpolor, et al.
Cancer Discovery (2022) Vol. 12, Iss. 6, pp. 1580-1597
Open Access | Times Cited: 174
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors
John A. Grout, Philémon Sirven, Andrew M. Leader, et al.
Cancer Discovery (2022) Vol. 12, Iss. 11, pp. 2606-2625
Open Access | Times Cited: 171
Activated fibroblasts in cancer: Perspectives and challenges
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 161
Page 1 - Next Page

Scroll to top